Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016)
Crossref DOI link: https://doi.org/10.1007/s40266-017-0466-6
Published Online: 2017-05-10
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wehling, Martin
Collins, Ronan
Gil, Victor M.
Hanon, Olivier
Hardt, Roland
Hoffmeister, Martin
Monteiro, Pedro
Quinn, Terence J.
Ropers, Dieter
Sergi, Giuseppe
Verheugt, Freek W. A.
Funding for this research was provided by:
Pfizer Germany
License valid from 2017-05-10